Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating cellular adoptive immunotherapy for stage III/IV ovarian cancer or primary peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Ovarian Cancer, Peritoneal Cavity Cancer | Phase 1 | Status: COMPLETED